AbbVie and Immunome have announced a worldwide multi-year collaboration and option agreement to discover multiple oncology targets using Immunome’s discovery engine. Under the terms of the agreement, ...

AbbVie has announced a new partnership with precision medicine company Frontier Medicines to discover and develop small molecules therapeutics for difficult-to-treat protein targets. The multi-year ...